Which has the lower trailing P/E, DXCM or ZTS?

ZTS has the lower trailing P/E: DXCM trades at 32.82 and ZTS at 12.03. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or ZTS?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus ZTS at 5.13%.

Does DXCM or ZTS pay a bigger dividend?

ZTS pays a dividend (2.85% yield), while DXCM has no payments in the available dividend history.

Is DXCM or ZTS more profitable?

ZTS runs the higher net margin — DXCM at 20.12% versus ZTS at 27.49%.

How have DXCM and ZTS total returns compared?

Over the past 10 years, DXCM delivered 13.78% and ZTS delivered 4.74% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs Zoetis Inc. (ZTS)

A side-by-side comparison of DexCom, Inc. and Zoetis Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$31.33B

$83.03HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

ZTS

Zoetis Inc.

$30.60B

$73.00HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — DXCM vs ZTS

growth of $100 · dividends reinvested · last 10y

DXCM +281.8% (+14.3%/yr)ZTS +58.8% (+4.7%/yr)DXCM compounded faster over this window

DXCM ZTS

DXCM vs ZTS: by the numbers

•DXCM is the larger company ($31.33B vs $30.60B market cap).
•ZTS trades at the lower trailing earnings multiple (12.03 vs 32.82 P/E), one valuation lens rather than an overall verdict.
•ZTS converts more revenue to profit (27.49% vs 20.12% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs 5.13% CAGR).
•ZTS pays a dividend (2.85% yield), while DXCM has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DXCM	ZTS
P/E ratio	32.82	12.03
Forward P/E	31.13	11.67
P/S ratio	6.31	3.22
P/B ratio	11.95	9.72
EV / EBITDA	22.54	9.58
FCF yield	4.48%	7.73%

Profitability

Metric	DXCM	ZTS
Gross margin	62.47%	70.87%
Operating margin	22.92%	37.00%
Net margin	20.12%	27.49%
ROE	38.14%	83.10%
ROIC	21.71%	21.63%

Dividends

Metric	DXCM	ZTS
Dividend yield	N/A	2.85%
Payout ratio	N/A	34.43%

Growth (annualized)

Metric	DXCM	ZTS
Revenue CAGR (5Y)	18.03%	5.13%
EPS CAGR (5Y)	10.31%	11.88%
FCF CAGR (5Y)	69.49%	6.81%
Total return CAGR (5Y)	-9.26%	-17.75%

Frequently asked

Which has the lower trailing P/E, DXCM or ZTS?: ZTS has the lower trailing P/E: DXCM trades at 32.82 and ZTS at 12.03. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or ZTS?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus ZTS at 5.13%.
Does DXCM or ZTS pay a bigger dividend?: ZTS pays a dividend (2.85% yield), while DXCM has no payments in the available dividend history.
Is DXCM or ZTS more profitable?: ZTS runs the higher net margin — DXCM at 20.12% versus ZTS at 27.49%.
How have DXCM and ZTS total returns compared?: Over the past 10 years, DXCM delivered 13.78% and ZTS delivered 4.74% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full ZTS analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio Zoetis P/E ratio Zoetis dividend yield DexCom ROE Zoetis ROE DexCom operating margin Zoetis operating margin DexCom revenue growth Zoetis revenue growth DexCom free cash flow Zoetis free cash flow

DexCom & Zoetis appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.